GYL Financial Synergies’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-6,535
Closed -$1.43M 376
2024
Q1
$1.43M Sell
6,535
-24
-0.4% -$5.29K 0.11% 156
2023
Q4
$1.49M Buy
6,559
+194
+3% +$40.8K 0.12% 151
2023
Q3
$1.28M Sell
6,365
-1,060
-14% -$224K 0.12% 151
2023
Q2
$1.54M Buy
+7,425
New +$1.44M 0.14% 134

Other funds holding LH

GYL Financial Synergies's LH Position: Q2 2024 in Review

GYL Financial Synergies sold out of Labcorp (LH) in Q2 2024, closing a stake of 6,535 shares — an estimated $1.43M sold.

GYL Financial Synergies first reported a position in LH in Q2 2023 and held it in 4 quarters. The position peaked at $1.54M in Q2 2023. 852 funds tracked by Wall St. Rank hold LH as of Q2 2024.

  • GYL Financial Synergies reported no remaining Labcorp position as of Q2 2024 after selling out during the quarter.
  • GYL Financial Synergies sold 6,535 Labcorp shares in Q2 2024, an estimated $1.43M.
  • GYL Financial Synergies first reported a position in Labcorp in Q2 2023 and held it in 4 quarters.
  • GYL Financial Synergies's Labcorp position peaked at $1.54M in Q2 2023.
  • 852 funds tracked by Wall St. Rank held Labcorp as of Q2 2024.

Based on GYL Financial Synergies's 13F filing for Q2 2024, filed 23 Jul 2024.